相关实验视频
Updated: Sep 17, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
肝素治疗药物的当前景观
Antonella Nai1,2, Laura Silvestri1,2, Michela Asperti3,4
1Regulation of Iron Metabolism Unit, Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milan, Italy.
肝素通过与ferroportin相互作用来调节铁. 针对这一轴为铁性疾病提供了新的治疗方法,如血色素变异症和贫血症,并正在开发肝素调节剂.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝素是系统铁平衡的主要调节剂.
- 它通过调节唯一的细胞铁出口者铁波丁来控制铁的吸收和释放.
- 失调的肝素表达与各种铁乱有关,包括铁过载和缺乏.
研究的目的:
- 在临床开发中审查当前的肝素治疗方法,以治疗与铁有关的疾病.
- 探索新的治疗策略,将肝素调节剂与其他治疗方法结合起来.
- 为了突出准肝-费罗波丁轴的治疗潜力.
主要方法:
- 审查现有的关于肝素治疗药物的文献.
- 对肝素调节剂的临床发展状态的分析.
- 对组合疗法的实验数据的探索.
主要成果:
- 肝素-费洛波丁轴是治疗铁性疾病的关键目标.
- 几种肝素调节剂正在临床开发中,旨在恢复正常的铁含量.
- 组合疗法,例如与luspatercept或TfR2向治疗,显示出增强贫血治疗的希望.
结论:
- 准肝素-费罗波丁相互作用是一个有前途的治疗途径.
- 肝素调节剂的开发为患有铁代谢疾病的患者提供了新的希望.
- 新的组合策略可能会进一步改善贫血的治疗结果.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Excretion: Influencing Factors
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...